Showing results (261-270 of 285) with videos related to

Sort By:
Pageof 29
Research Square|June 4, 2026
Crimean-Congo hemorrhagic fever virus protein GP38 from isolate M18-China confers broad immunological breadthAlbert Wang, Stephanie R Monticelli, Christy K Hjorth, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 20, 2022
A Delphi consensus on the nomenclature and diagnosis of lichen planus pigmentosus and related entitiesRashmi Sarkar, Keshavamurthy Vinay, Anuradha Bishnoi, et al.
The Journal of Experimental Medicine|March 27, 2013
CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigensDalam Ly, Anne G Kasmar, Tan-Yun Cheng, et al.
Bioconjugate Chemistry|August 8, 2018
Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell ActivationNatacha Veerapen, Shalu Sharma Kharkwal, Peter Jervis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 20, 2010
A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivityVincent Lombardi, Philippe Stock, Abinav K Singh, et al.
Indian Journal of Dermatology|December 22, 2017
Medical Management of Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert GroupRashmi Sarkar, Narendra Gokhale, Kiran Godse, et al.
Vaccine|September 26, 2020
BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosisSangeeta Tiwari, Taru S Dutt, Bing Chen, et al.
Nature Medicine|September 6, 2011
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosisKari A Sweeney, Dee N Dao, Michael F Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2011
Fine tuning by human CD1e of lipid-specific immune responsesFederica Facciotti, Marco Cavallari, Catherine Angénieux, et al.
The Journal of Clinical Investigation|October 15, 2005
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogsEdward S Morris, Kelli P A MacDonald, Vanessa Rowe, et al.
Pageof 29